Bergenbio ASA (BGBIO) — Cash Flow-to-Debt Ratio
Bergenbio ASA (BGBIO) has a Cash Flow-to-Debt Ratio of -4.63x as of December 2024, meaning its operating cash flow of Nkr-153.24 Million could theoretically repay -5% of its total liabilities (Nkr33.09 Million) in one year. See Bergenbio ASA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bergenbio ASA Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Bergenbio ASA across 10 annual periods. Also explore Bergenbio ASA annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bergenbio ASA (2015–2024)
Year-by-year debt coverage analysis for Bergenbio ASA. For market capitalisation and broader financial context, see BGBIO stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.63x | Nkr-153.24 Million | Nkr33.09 Million | ▲ +22.6% |
| 2023 | -5.99x | Nkr-280.50 Million | Nkr46.86 Million | ▼ -62.4% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr65.81 Million | ▼ -33.7% |
| 2020 | -3.45x | Nkr-234.29 Million | Nkr67.97 Million | ▲ +5.2% |
| 2019 | -3.64x | Nkr-184.15 Million | Nkr50.62 Million | ▲ +19.1% |
| 2018 | -4.49x | Nkr-186.71 Million | Nkr41.55 Million | ▲ +9.1% |
| 2017 | -4.95x | Nkr-168.11 Million | Nkr33.99 Million | ▲ +15.4% |
| 2016 | -5.85x | Nkr-124.31 Million | Nkr21.27 Million | ▼ -64.0% |
| 2015 | -3.56x | Nkr-62.90 Million | Nkr17.64 Million | — |